Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes

被引:566
作者
Barouch, DH
Kunstman, J
Kuroda, MJ
Schmitz, JE
Santra, S
Peyerl, FW
Krivulka, GR
Beaudry, K
Lifton, MA
Gorgone, DA
Montefiori, DC
Lewis, MG
Wolinsky, SM
Letvin, NL
机构
[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA
[2] Northwestern Univ, Sch Med, Dept Med, Chicago, IL 60611 USA
[3] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA
[4] So Res Inst, Frederick, MD 21701 USA
关键词
D O I
10.1038/415335a
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Potent virus-specific cytotoxic T lymphocyte (CTL) responses elicited by candidate AIDS vaccines have recently been shown to control viral replication and prevent clinical disease progression after pathogenic viral challenges in rhesus monkeys(1-4). Here we show that viral escape from CTL recognition can result in the eventual failure of this partial immune protection. Viral mutations that escape from CTL recognition have been previously described in humans infected with human immunodeficiency virus (HIV)(5-10) and monkeys infected with simian immunodeficiency virus (SIV)(11-13). In a cohort of rhesus monkeys that were vaccinated and subsequently infected with a pathogenic hybrid simian-human immunodeficiency virus (SHIV), the frequency of viral sequence mutations within CTL epitopes correlated with the level of viral replication. A single nucleotide mutation within an immunodominant Gag CTL epitope in an animal with undetectable plasma viral RNA resulted in viral escape from CTLs, a burst of viral replication, clinical disease progression, and death from AIDS-related complications. These data indicate that viral escape from CTL recognition may be a major limitation of the CTL-based AIDS vaccines that are likely to be administered to large human populations over the next several years.
引用
收藏
页码:335 / 339
页数:5
相关论文
共 27 条
  • [1] Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia
    Allen, TM
    O'Connor, DH
    Jing, PC
    Dzuris, JL
    Mothé, BR
    Vogel, TU
    Dunphy, E
    Liebl, ME
    Emerson, C
    Wilson, N
    Kunstman, KJ
    Wang, XC
    Allison, DB
    Hughes, AL
    Desrosiers, RC
    Altman, JD
    Wolinsky, SM
    Sette, A
    Watkins, DI
    [J]. NATURE, 2000, 407 (6802) : 386 - 390
  • [2] Allen TM, 1998, J IMMUNOL, V160, P6062
  • [3] CD8+ lymphocytes from simian immunodeficiency virus-infected rhesus macaques recognize 14 different epitopes bound by the major histocompatibility complex class I molecule Mamu-A*01:: Implications for vaccine design and testing
    Allen, TM
    Mothé, BR
    Sidney, J
    Jing, PC
    Dzuris, JL
    Liebl, ME
    Vogel, TU
    O'Connor, DH
    Wang, XC
    Wussow, MC
    Thomson, JA
    Altman, JD
    Watkins, DI
    Sette, A
    [J]. JOURNAL OF VIROLOGY, 2001, 75 (02) : 738 - 749
  • [4] Phenotypic analysis of antigen-specific T lymphocytes
    Altman, JD
    Moss, PAH
    Goulder, PJR
    Barouch, DH
    McHeyzerWilliams, MG
    Bell, JI
    McMichael, AJ
    Davis, MM
    [J]. SCIENCE, 1996, 274 (5284) : 94 - 96
  • [5] Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine
    Amara, RR
    Villinger, F
    Altman, JD
    Lydy, SL
    O'Neil, SP
    Staprans, SI
    Montefiori, DC
    Xu, Y
    Herndon, JG
    Wyatt, LS
    Candido, MA
    Kozyr, NL
    Earl, PL
    Smith, JM
    Ma, HL
    Grimm, BD
    Hulsey, ML
    Miller, J
    McClure, HM
    McNicholl, JM
    Moss, B
    Robinson, HL
    [J]. SCIENCE, 2001, 292 (5514) : 69 - 74
  • [6] Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination
    Barouch, DH
    Santra, S
    Schmitz, JE
    Kuroda, MJ
    Fu, TM
    Wagner, W
    Bilska, M
    Craiu, A
    Zheng, XX
    Krivulka, GR
    Beaudry, K
    Lifton, MA
    Nickerson, CE
    Trigona, WL
    Punt, K
    Freed, DC
    Guan, LM
    Dubey, S
    Casimiro, D
    Simon, A
    Davies, ME
    Chastain, M
    Strom, TB
    Gelman, RS
    Montefiori, DC
    Lewis, MG
    Emini, EA
    Shiver, JW
    Letvin, NL
    [J]. SCIENCE, 2000, 290 (5491) : 486 - 492
  • [7] Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus
    Borrow, P
    Lewicki, H
    Wei, XP
    Horwitz, MS
    Peffer, N
    Meyers, H
    Nelson, JA
    Gairin, JE
    Hahn, BH
    Oldstone, MBA
    Shaw, GM
    [J]. NATURE MEDICINE, 1997, 3 (02) : 205 - 211
  • [8] Simian immunodeficiency virus evades a dominant epitope-specific cytotoxic T lymphocyte response through a mutation resulting in the accelerated dissociation of viral peptide and MHC class I
    Chen, ZW
    Craiu, A
    Shen, L
    Kuroda, MJ
    Iroku, UC
    Watkins, DI
    Voss, G
    Letvin, NL
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 164 (12) : 6474 - 6479
  • [9] Characterization of primary isolate-like variants of simian-human immunodeficiency virus
    Crawford, JM
    Earl, PL
    Moss, B
    Reimann, KA
    Wyand, MS
    Manson, KH
    Bilska, M
    Zhou, JT
    Pauza, CD
    Parren, PWHI
    Burton, DR
    Sodroski, JG
    Letvin, NL
    Montefiori, DC
    [J]. JOURNAL OF VIROLOGY, 1999, 73 (12) : 10199 - 10207
  • [10] Use of major histocompatibility complex class I/peptide/β2M tetramers to quantitate CD8+ cytotoxic T lymphocytes specific for dominant and nondominant viral epitopes in simian-human immunodeficiency virus-infected rhesus monkeys
    Egan, MA
    Kuroda, MJ
    Schmitz, JE
    Charini, WA
    Lord, CI
    Forman, MA
    Letvin, NL
    [J]. JOURNAL OF VIROLOGY, 1999, 73 (07) : 5466 - 5472